Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies [PDF]
, 2009 Aim: PankoMab is a novel antibody that recognizes a tumor-specific epitope of Mucin 1 (MUC1). The aim of this study was the evaluation of PankoMab as a potential diagnostic tool and its comparison with two established antibodies against MUC1 in human ...
Dian, Darius +7 more
core +1 more source
Clinical-pathological features of an occult mixed mucinous male breast cancer. a case report [PDF]
, 2017 Mucinous carcinoma of the male breast is an uncommon malignant breast neoplasm and its diagnoses remain difficult. It is probably due to such a low rate of breast cancer cases that men tend to be diagnosed at an older age than women and with a later ...
Bonifacino, Adriana +7 more
core +1 more source
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer [PDF]
, 2012 In our previous work we showed that NGAL, a protein involved in the regulation of proliferation and differentiation, is overexpressed in human breast cancer (BC) and predicts poor prognosis.
Arnold, Norbert +18 more
core +6 more sources
Expression and intracellular localization of FKHRL1 in mammary gland neoplasms. [PDF]
, 2004 FKHRL1 (FOXO3a), a member of the Forkhead family of genes, has been considered to be involved in the development of breast tumors; however, the in vivo expression and activation status of FKHRL1 in breast tumors still remains unclear.
Akagi, Tadaatsu +8 more
core +1 more source
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma [PDF]
, 2007 Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopathological parameters, coexpression of other biological markers and prognosis.
Arnerlov C +10 more
core +2 more sources
Unusual Metastasis of Lobular Carcinoma of the Breast
Haseki Tıp Bülteni, 2018 Invasive lobular carcinoma is the second most common type of invasive breast cancer accounting for approximately 5-10% of all invasive breast carcinomas. The metastatic patterns of lobular and ductal carcinomas are significantly different.
Songül Peltek Özer, Saime Gül Barut
doaj +1 more source
A taxonomy of epithelial human cancer and their metastases [PDF]
, 2009 Background: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets.
Olivier Gevaert +76 more
core +3 more sources
Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells.
PLoS ONE, 2017 BackgroundResistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression.
Wen Che, Yun Bao, Feng Tang
doaj +1 more source
Breast: Secretory ductal carcinoma [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Review on Breast: Secretory ductal carcinoma, with data on clinics, and the genes involved.
openaire +1 more source
Predicting invasive breast cancer versus DCIS in different age groups. [PDF]
, 2014 BackgroundIncreasing focus on potentially unnecessary diagnosis and treatment of certain breast cancers prompted our investigation of whether clinical and mammographic features predictive of invasive breast cancer versus ductal carcinoma in situ (DCIS ...
Alagoz, Oguzhan +7 more
core +1 more source